Basel, 17 March 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of cobas pure integrated solutions in countries accepting the CE mark.3 This new compact analyser combines three ...
This new compact analyser combines clinical chemistry, immunoassay and Ion Concentration Measurement (ISE) diagnostic testing on a single platform, helping labs simplify daily operations with limited ...
INDIANAPOLIS, Sept. 19, 2022 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas ® pure integrated solutions, ...
With a footprint of just two square meters, this new analyser provides small to medium sized labs with access to more than 230 diagnostic tests 2 across a wide-range of disease areas including ...
(RTTNews) - Swiss drug major Roche Group (RHHBY) announced Wednesday the launch of cobas pure integrated solutions in countries accepting the CE mark. The new compact analyser combines three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback